A/Prof Hui-Peng (Peng) Lee Department of Haematology
Flinders Medical Centre
South Australia

Dr Annette Neylon
New Zealand Blood Service
Dunedin, New Zealand

Dr Matthew (Matt) Wright
Head of laboratory Haematology Department
Fiona Stanley Hospital

Perth  WA

Matt Wright is a clinical and lab Haematologist from Fiona Stanley Hospital in Perth.

He completed training in Sydney before enjoying a transplant fellowship in Vancouver, and later a sabbatical in Cambridge focussed on MPN.

His clinical interests are myeloid neoplasms and allotransplant, and he is a passionate teacher of laboratory medicine. Matt is a national examiner for the RCPA and RACP, and enjoys travelling to teach in the Asia-pacific region.

In his spare time Matt likes ocean swimming and losing to his two boys at Golf.

Dr Adam Bryant

Senior Staff Specialist

Liverpool Hospital

Adam Bryant is a Senior Staff Specialist at Liverpool Hospital where he has worked since 2012 as a development member of the allogeneic BMT program which commenced at this time. Adam’s other specific subspecialty interest is as a core member of the Liverpool Hospital Myeloma Subspecialty Unit. Adam and his colleagues are responsible for an exceptionally large practice of myeloma patients. This unit has been a strong recruiter for many Phase 2 and 3 clinical studies of myeloma therapies. Adam has been the Principle Investigator of several myeloma trials and is an active member of the Australia Leukaemia and Lymphoma Group Myeloma Working Party. 

His major other role is as Chair of the rapidly expanding Haematology Clinical Trials Unit of South Western Sydney that aims to bring new and innovative therapies to the patients of this previously underserviced region. Adam has also had various roles with the NSW Cancer Institute, in particular as the Chair of the EviQ Haematology Reference Committee.

A/Prof Andrea Henden

Clinical Haematologist

Royal Brisbane and Women's Hospital

Queensland

A/Prof Andrea Henden (BSc MBBS (Hons) FRACP FRCPA PhD) is a clinical Haematologist and Bone Marrow Transplant physician at the Royal Brisbane and Women's Hospital in Brisbane, Australia and a holder of a Metro North Clinician Research Fellowship. She has a clinical interest in transplantation and cellular therapies, and the infectious complications of these treatments. A/Prof Henden is also a research officer in the Translational Cancer Immunotherapy Laboratory at QIMR Berghofer Medical Research Institute. Her research focusses on transplant immunology and current active projects include cellular therapies for infection, and the role of the microbiome and metabolism on T cell function in the context of transplantation and cellular therapy. She is the Principal Investigator on a number of Investigator Initiated Clinical Trials bringing novel immunotherapies to the clinic, with a focus toward treating complications of immunotherapies.  

Dr Nicole Wong Doo
Clinical and laboratory haematologist

Concord Hospital

New South Wales

Dr Nicole Wong Doo (MBBS (Hons), PhD, FRACP, FRCPA, GradCert[ClinTch]) is a clinical and laboratory haematologist at Concord Repatriation General Hospital, senior lecturer at Concord Clinical School and Honorary Research Associate at the Cancer Council Victoria. As the Director of the Haematology Clinical Research Unit at Concord Hospital, she leads a team of 25 in the delivery of clinical trials embedded within clinical practice and clinical-translational research. Since completing a PhD in lymphoma and myeloma epigenetics at the University of Melbourne, she has built a growing portfolio of clinical research, as the Australian principal investigator of the ALLG HD13 RADAR trial in hodgkin lymphoma supported by the MRFF. She has ongoing research interests in lymphoma and multiple myeloma clinical trials and supportive care, including being a member of the ALLG Multiple Myeloma, Lymphoma and Supportive Care Scientific Working Parties, member of the Australasian Lymphoma Alliance and on the Steering Committee of the Australasian Myeloma Research Consortium. With a growing profile in patient-reported outcomes (PRO) research, she leads a PRO study in Oral therapy for Blood Diseases and is PI of a digital research project called MyHodgkin MyHealth, a mobile App for patient-entered health outcomes in Hodgkin lymphoma. Dr Wong Doo is dedicated to promoting excellence in Haematology in the Asia-Pacific region and works to deliver training and education as a member of the Royal College of Pathologists Australasia Pathology Education Outreach Committee (PEOC).

Dr Sumita Ratnasingam

Clinical Haematologist

University Hospital Geelong

Victoria

Dr. Sumi Ratnasingam (AdvDipMedSci, BMedSci, MBBS, FRACP, FRCPA, GCertCncrSc) is a senior clinical haematologist at University Hospital Geelong, with extensive experience in malignant haematology. In addition to her clinical roles, Sumi is a senior lecturer for Deakin University and holds other leadership positions within the hospital. Sumi’s work in haematology extends beyond clinical care, with active involvement in research and clinical trials. She has served as a principal investigator for lymphoma studies and is a regular contributor to national and international publications through her involvement with ALA (Australasian Lymphoma Alliance) and ALLG (Australasian Leukaemia & Lymphoma Group). She is currently the co-medical secretary for the ALLG Lymphoma Working Scientific Party (SWP). Dedicated to professional development, Sumi plays a crucial role in mentoring and training future physicians and haematologists. She is a local FRACP examiner as well as a member of the CJCT (Committee for Joint College Training) and CAPHAT (Central Appointments Process for Haematology Advanced Training for Victoria) as a HSANZ representative. Sumi is an advocate for women and minority ethnic groups in the field. She has recently been appointed to the global Women in Lymphoma’s (WIL) sub-committee of emerging WIL collaborators. Her ongoing contributions to haematology reflect her commitment to advancing care for patients while fostering leadership within the broader haematology community. Outside of work, Sumi enjoys spending time with family and friends. She is still trying to achieve that elusive life-work balance and relaxes by playing music, travelling and attending art exhibits. 

Dr Andrew Guirguis

Victoria

Dr Andrew Guirguis is a Clinical Haematologist at Austin Health and a Clinical Lab Head at the Olivia Newton-John Cancer Research Institute in Melbourne, Victoria since 2024. His clinical and research interests focus on understanding and targeting drivers of pre-leukaemic myeloid neoplasms, including the myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and myeloproliferative neoplasms (MPN). A University of Melbourne graduate, Andrew holds dual fellowships with the Royal Australasian College of Physicians (RACP) and the Royal College of Pathologists of Australasia (RCPA). He completed haematology training at the Alfred Hospital and a PhD at the Australian Centre for Blood Diseases, earning the HSANZ Baikie Medal. His postdoctoral research includes fellowships under Professor Ben Ebert at the Dana-Farber Cancer Institute and Professor Mark Dawson at the Peter MacCallum Cancer Centre. Andrew serves on the Acute Leukaemia and Laboratory Science Working Parties within the Australasian Leukaemia and Lymphoma Group (ALLG). Outside of work, he enjoys traveling, long-distance running and playing the piano – though he admits the latter two are still works in progress.

Dr Prudence (Pru) Smith
Haematologist

Hobart Hospital

Tasmania

Pru Smith is a haematologist at Hobart Hospital

Stephanie Anderson
Early Career Representative

Stephanie Anderson is the Early Career representative for HSANZ.  She is currently undertaking a PhD titled ‘Gene editing to cure Sickle Cell Disease’ at the Australian Centre for Blood Diseases and is a recipient of the HSANZ New Investigator Scholarship. Stephanie undertook a Bachelor of Medical Science before graduating from medicine at the University of Sydney. She has dual Fellowship of the Royal Australasian College of Physicians and the Royal College of Pathologists of Australasia. Stephanie is an avid hockey player, and enjoys taking her dog for walks along St Kilda beach. 

Andrew (Andy) Steele
HSANZ Nurses Group Lead

Andy started working in Oncology upon qualification in 1991 in the UK. His first role in Haematology was 3 years later at Derriford Hospital, Plymouth, and he became Charge nurse there in 1998. In 2000, Andy moved to Kalgoorlie, WA, working in Restorative and Palliative care as a manager and stayed there for 2 years before moving to Perth to work on the Haematology ward, G73. He stayed there for 14 years night and day and then moved to the Haematology Day Ward as Clinical Nurse Specialist and then Manager in 2014. He has been a Nurses Representative for the HSANZ Nurses group WA since 2015 and became vice president of the national nurses group in 2020. Furthermore, he has an interest in Change Theory, presenting several times at Blood Conferences as well as organising and chairing the nurse’s stream of Blood 2019 in Perth.  He has obtained a post grad certificate in Leading Great Care.